Success in infrastructure innovation is often determined by execution and market adoption rather than the speed at which capital can be deployed. Murphy Capital is built around this reality, recognising that successful Infratech businesses are developed over years, not funding cycles.
Patient capital gives founders the flexibility to refine their technology, strengthen their teams and establish commercial traction without being constrained by a predetermined exit timetable. Its value lies not simply in providing funding for longer, but in ensuring that capital remains aligned with the time required to create resilient, scalable businesses capable of delivering lasting impact across the infrastructure sector.
Capital aligned with long-term growth
A longer-term mindset is becoming increasingly important across infrastructure investment. The UK Government’s 10-Year Infrastructure Strategy is designed to provide greater certainty and stability around the country’s infrastructure pipeline, recognising that successful infrastructure delivery depends on consistent investment, long-term planning and stable policy direction.[1]
The same principle applies to Infratech. Developing and scaling innovative solutions requires time to validate performance, secure customer adoption and navigate complex procurement environments. As a result, the success of many Infratech businesses is shaped less by the availability of capital and more by whether that capital remains aligned with the pace at which infrastructure markets adopt innovation.
This shift is also becoming increasingly evident across the investment community. McKinsey’s 2026 analysis of global infrastructure investment highlights lengthening investment horizons and a growing focus on creating value throughout the ownership period rather than relying solely on financial engineering or short-term exits.[2] The findings reflect a broader recognition that sustainable value creation often requires investors to take a longer-term view of growth.
For founders, this alignment can be a significant advantage. Longer investment horizons provide greater freedom to invest in product development, recruit senior talent, enter new markets and build strategic customer relationships. When investors and management teams share a common time horizon, decisions can be driven by long-term value creation rather than short-term liquidity events.
Patient capital therefore works best when the investor’s horizon is aligned with the company’s ambition.
An investor built into the industry
For founders, patient capital is most valuable when it comes with the expertise and connections to make that time count. Sector knowledge can support better-informed decisions, industry networks can open new commercial routes, and practical expertise can help businesses navigate the challenges that come with growth.
Murphy Capital brings these elements together. As part of Murphy, it combines patient investment with the capabilities of a global infrastructure business.
Murphy’s 75 years of delivery experience gives portfolio companies access to people with deep infrastructure expertise. Murphy Capital can support founders with strategy, recruitment, operational development and go-to-market planning, drawing on the wider Murphy experience and networks as businesses grow.
Where there is a strong operational fit, Murphy can support pilots, trials and deployment opportunities within relevant parts of its business. This can help founders strengthen commercial validation, refine their products in real-world environments and build momentum with future customers. This puts Murphy Capital in a distinctive position, investing in a company’s growth while also helping it build commercial momentum.
This makes our approach to patient capital active rather than passive. Funding provides businesses with the time to build, while Murphy’s infrastructure expertise, customer role and international footprint can help founders use that time to create lasting value.
[1]HM Treasury, 2025. “UK Infrastructure: A 10 Year Strategy”. (Accessed: September 2026).
[2] McKinsey, 2026. “Global Infrastructure Report 2026”. (Accessed: September 2026).
Building value on founders’ terms
Patient capital ultimately gives founders greater choice over what a successful future looks like. Without a fixed exit timetable, businesses have more freedom to invest in the capabilities that matter, pursue the right growth opportunities and make decisions around long-term value.
Murphy Capital’s approach is designed to preserve that flexibility while giving founders the support to be ambitious. Whether the eventual path is acquisition, further growth or long-term independence, the focus is on building a stronger business rather than working backwards from an exit date.
For the next generation of Infratech businesses, competitive advantage will not be defined by access to capital alone, but by access to capital that remains aligned with the realities of infrastructure markets. Patient capital gives founders the time, support and flexibility needed to transform proven technologies into enduring businesses capable of creating long-term value across the infrastructure sector.
The role of patient capital is not simply to fund growth. It is to give founders the time, support and flexibility needed to build enduring businesses. Further insight into the investment trends shaping UK Infratech is explored in Murphy Capital’s newly published report UK Infratech: From Innovation to Scale.